{
  "id": 9104726,
  "title": "Novo Still Has Work to Do to Build Investor Confidence, CEO Says",
  "url": "https://urgent.news/2026/09/22/novo-still-has-work-to-do-to-build-investor-confidence-ceo-says",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-22T07:09:54.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-09-22/novo-still-has-work-to-do-to-build-confidence-ceo-says-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novo CEO Mike Doustdar discusses investor confidence, drug testing and the potential for expanding the firm's obesity offerings. \"We should also have a mindset that we don't have a patent or a monopoly on all the good ideas,\" Doustdar tells Bloomberg Television. \"When there is a gap, strategically or scientifically, we're looking outside to see how we can fill the gaps.\" (Source: Bloomberg)",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}